The FDA's New Statement about AI in Medical Devices

On January 6, 2026, FDA commissioner Martin Makary announced the federal agency will not require regulation for consumer wearables and medical devices. Devices like this include calorie calculators, sleep monitors, or ChatGPT Health. The FDA will continue to subject tools used for clinical purposes, such as blood pressure monitors. For non-clinical tools, the FDA will allow the market and doctors to determine which products are reliable to recommend.

The FDA’s Rationale

The agency wants to give tech companies the creative freedom to innovate without need of government regulation. Rather than trying to attempt to regulate every information-sharing tool, the FDA will allow the AI field to develop.

It is important to mention, the FDA’s aim is to balance AI innovation with guarding against safety concerns. The agency further warns patients should not change medical treatment based on AI meant for general estimation.

Sourcehttps://healthexec.com/topics/healthcare-management/healthcare-policy/fda-ai-powered-medical-devices-simply-providing-information-are-not-subject-regulation